- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 1/107 - General processes for the preparation of peptides by chemical modification of precursor peptides
Patent holdings for IPC class C07K 1/107
Total number of patents in this class: 1060
10-year publication summary
|
77
|
78
|
75
|
73
|
83
|
77
|
99
|
81
|
93
|
30
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
27 |
| Forschungsverbund Berlin e.V. | 194 |
16 |
| Ludwig-Maximilians-Universitat Munchen | 329 |
14 |
| Janssen Pharmaceutica N.V. | 3839 |
13 |
| Quiapeg Pharmaceuticals AB | 46 |
13 |
| Bristol-myers Squibb Company | 5080 |
12 |
| President and Fellows of Harvard College | 5792 |
12 |
| Massachusetts Institute of Technology | 9795 |
11 |
| Takeda Pharmaceutical Company Limited | 2961 |
11 |
| Pfizer Inc. | 3322 |
10 |
| Novo Nordisk A/S | 2324 |
9 |
| F. Hoffmann-La Roche AG | 7958 |
8 |
| NBE Therapeutics AG | 38 |
8 |
| New York University | 1635 |
8 |
| Bicyclerd Limited | 130 |
8 |
| Aileron Therapeutics, Inc. | 85 |
7 |
| Hybio Pharmaceutical Co., Ltd. | 119 |
7 |
| Jiangsu Hengrui Medicine Co., Ltd. | 780 |
7 |
| Roche Sequencing Solutions, Inc. | 565 |
7 |
| Ubiprotein, Corp. | 10 |
7 |
| Other owners | 845 |